Wnt-4



Wnt-4

S1SS1N2NN2W3WW3L4LL4Y5YY5L6LL6A7AA7K8KK8L9LL9S10SS10S11SS11V12VV12G13GG13S14SS14I15II15S16SS16E17EE17E18EE18E19EE19T20TT20C21CC21E22EE22K23KK23L24LL24K25KK25G26GG26L27LL27I28II28Q29QQ29R30RR30Q31QQ31V32VV32Q33QQ33M34MM34C35CC35K36KK36R37RR37N38NN38L39LL39E40EE40V41VV41M42MM42D43DD43S44SS44V45VV45R46RR46R47RR47... and 282 more residue(s)...... and 282 more residue(s)

SMILES None
InChIKey None
Sequence SNWLYLAKLSSVGSISEEETCEKLKGLIQRQVQMCKRNLEVMDSVRRGAQLAIEECQYQFRNRRWNCSTLDSLPVFGKVVTQGTREAAFVYAISSAGVAFAVTRACSSGELEKCGCDRTVHGVSPQGFQWSGCSDNIAYGVAFSQSFVDVRERSKGASSSRALMNLHNNEAGRKAILTHMRVECKCHGVSGSCEVKTCWRAVPPFRQVGHALKEKFDGATEVEPRRVGSSRALVPRNAQFKPHTDEDLVYLEPSPDFCEQDMRSGVLGTRGRTCNKTSKAIDGCELLCCGRGFHTAQVELAERCSCKFHWCCFVKCRQCQRLVELHTCR

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)

Database connections


No bioactivity data available.

Wnt-4

S1SS1N2NN2W3WW3L4LL4Y5YY5L6LL6A7AA7K8KK8L9LL9S10SS10S11SS11V12VV12G13GG13S14SS14I15II15S16SS16E17EE17E18EE18E19EE19T20TT20C21CC21E22EE22K23KK23L24LL24K25KK25G26GG26L27LL27I28II28Q29QQ29R30RR30Q31QQ31V32VV32Q33QQ33M34MM34C35CC35K36KK36R37RR37N38NN38L39LL39E40EE40V41VV41M42MM42D43DD43S44SS44V45VV45R46RR46R47RR47... and 282 more residue(s)...... and 282 more residue(s)

Drug properties

Molecular type Peptide
Physiological/Surrogate Endogenous
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections


Compound is not listed as a drug.